Community Bank N.A. Has $1.44 Million Holdings in Colgate-Palmolive (NYSE:CL)

Community Bank N.A. cut its stake in Colgate-Palmolive (NYSE:CL) by 2.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 18,000 shares of the company’s stock after selling 404 shares during the period. Community Bank N.A.’s holdings in Colgate-Palmolive were worth $1,435,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently modified their holdings of CL. &PARTNERS lifted its stake in shares of Colgate-Palmolive by 0.7% in the 4th quarter. &PARTNERS now owns 17,643 shares of the company’s stock valued at $1,406,000 after acquiring an additional 129 shares during the last quarter. West Branch Capital LLC increased its holdings in Colgate-Palmolive by 24.0% in the fourth quarter. West Branch Capital LLC now owns 682 shares of the company’s stock valued at $54,000 after purchasing an additional 132 shares during the period. First Foundation Advisors increased its holdings in Colgate-Palmolive by 2.7% in the third quarter. First Foundation Advisors now owns 5,226 shares of the company’s stock valued at $372,000 after purchasing an additional 136 shares during the period. Waldron Private Wealth LLC increased its holdings in Colgate-Palmolive by 2.7% in the third quarter. Waldron Private Wealth LLC now owns 5,361 shares of the company’s stock valued at $381,000 after purchasing an additional 140 shares during the period. Finally, Autumn Glory Partners LLC increased its holdings in Colgate-Palmolive by 2.7% in the fourth quarter. Autumn Glory Partners LLC now owns 5,319 shares of the company’s stock valued at $424,000 after purchasing an additional 140 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Wall Street Analyst Weigh In

CL has been the subject of a number of recent research reports. Barclays increased their price objective on Colgate-Palmolive from $82.00 to $84.00 and gave the company an “equal weight” rating in a report on Friday, April 12th. Citigroup raised their target price on Colgate-Palmolive from $95.00 to $100.00 and gave the company a “buy” rating in a research note on Tuesday, April 16th. UBS Group raised their target price on Colgate-Palmolive from $93.00 to $95.00 and gave the company a “buy” rating in a research note on Monday, January 29th. Raymond James upgraded Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 target price for the company in a research note on Monday, January 29th. Finally, JPMorgan Chase & Co. raised their price target on shares of Colgate-Palmolive from $88.00 to $90.00 and gave the company an “overweight” rating in a research report on Thursday, January 18th. Three research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $89.50.

Colgate-Palmolive Price Performance

Shares of CL traded up $0.52 during mid-day trading on Thursday, reaching $89.39. 3,530,318 shares of the stock traded hands, compared to its average volume of 4,535,253. The firm has a fifty day moving average price of $87.40 and a 200 day moving average price of $81.25. The company has a market cap of $73.48 billion, a price-to-earnings ratio of 31.97, a price-to-earnings-growth ratio of 3.33 and a beta of 0.42. The company has a current ratio of 1.11, a quick ratio of 0.71 and a debt-to-equity ratio of 8.59. Colgate-Palmolive has a 1 year low of $67.62 and a 1 year high of $90.37.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, January 26th. The company reported $0.87 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.85 by $0.02. Colgate-Palmolive had a net margin of 11.82% and a return on equity of 509.75%. The company had revenue of $4.95 billion during the quarter, compared to the consensus estimate of $4.89 billion. During the same period in the previous year, the firm posted $0.77 EPS. The firm’s revenue was up 6.9% compared to the same quarter last year. As a group, equities research analysts predict that Colgate-Palmolive will post 3.5 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Monday, April 22nd will be paid a $0.50 dividend. The ex-dividend date is Friday, April 19th. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.48. This represents a $2.00 annualized dividend and a yield of 2.24%. Colgate-Palmolive’s payout ratio is currently 71.94%.

Insiders Place Their Bets

In other Colgate-Palmolive news, CEO Noel R. Wallace sold 50,000 shares of the business’s stock in a transaction on Monday, February 12th. The shares were sold at an average price of $83.15, for a total value of $4,157,500.00. Following the completion of the sale, the chief executive officer now directly owns 274,179 shares of the company’s stock, valued at $22,797,983.85. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Colgate-Palmolive news, CEO Noel R. Wallace sold 50,000 shares of the business’s stock in a transaction on Monday, February 12th. The shares were sold at an average price of $83.15, for a total value of $4,157,500.00. Following the completion of the sale, the chief executive officer now directly owns 274,179 shares of the company’s stock, valued at $22,797,983.85. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Noel R. Wallace sold 69,948 shares of the business’s stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $84.22, for a total transaction of $5,891,020.56. Following the completion of the sale, the chief executive officer now directly owns 286,881 shares of the company’s stock, valued at $24,161,117.82. The disclosure for this sale can be found here. Insiders sold 232,371 shares of company stock valued at $19,505,099 over the last three months. Insiders own 0.34% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.